TELL ME MORE
ABOUT THIS CLINICAL TRIAL for MIGRAINES in CHILDREN
This is an Double Blind, Placebo Controlled Phase 3 Study of an Investigational Medicine for Migraine Patients Ages 6 – 17 Years.
Clinical Trial for Migraines in Children
Study Location(s): Owensboro and Bowling Green Kentucky, Evansville Indiana
Migraine is one of the most common neurological conditions in pediatrics with a prevalence of approximately 8% in children under 20 years of age. Migraine occurs more frequently in adolescents compared with the younger pediatric age groups. There is a significant increase in migraine incidence in females after puberty. In children and adolescents, headache and migraine can result in missed school days, poorer academic performance and a negative impact on quality of life. There are few treatments approved for the acute treatment of migraine in adolescents, and only 1 treatment approved for children aged 6 to 11 years. Thus, there remains a significant unmet need for the acute treatment of migraine in children and adolescents. This is a double-blind, placebo-controlled, phase 3 study of an investigational medicine for acute migraine in children ages 6 – 17. Patient volunteers will have an option to enter a 52 week long-term open-label extension study. Click here for more information on living with pediatric migraine.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimbursement up to $550 may be available.
Watch a short presentation on Migraines
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ADHD A Long-term study Evaluating the Safety of an Investigational Medication Administered with a Psychostimulant in children with ADHD | Evansville | Enrolling | 6 - 17 | $1500 | Request Info | |
| ADHD A placebo controlled study evaluating the Efficacy and Safety of an Investigational Medication for Children with ADHD | Bowling Green Evansville Owensboro | Enrolling | 4-12 | $416-$1040 | Request Info | |
| COPD A Phase 3 Study to Evaluate the Efficacy and Safety of Two Dose Regimens of an Investigational Medication in Participants with Symptomatic COPD | Bowling Green | Enrolling | 40+ | Up to $1200 | Request Info | |
| COPD Safety, Efficacy and Tolerance study for moderate to severe COPD | Owensboro | Enrolling | 40-85 | Up to $750 | Request Info | |
| DIABETES (T2DM) Safety and Efficacy of an Investigational Medicine for pediatric and adolescent patients with type 2 diabetes. | Evansville | Enrollin | 10-17 | Up to $875 | Request Info | |
| DIABETES (T2DM) Study to Evaluate the Efficacy and Safety of an Investigation Medication as a Weekly Basal Insulin Compared to Insulin Degludec in Insulin Naïve Adults with Type 2 Diabetes | Bowling Green Evansville Owensboro | Enrolling | 18 Years & Up | $1625 | Request Info | |
| DIABETES (T2DM) Study to Evaluate the Long-Term Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults When Initiating Treatment Early in the Course of Type 2 Diabetes | Bowling Green Evansville Owensboro | Enrolling | 18 Years & Up | Up to $3125 | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study of a topical investigational medicine with open-label extension in patients with moderate to severe eczema | Owensboro Evansville | Enrolling | 2-17 Years Old | $1470 | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled study of a topical investigational medicine in patients with moderate to severe eczema | Evansville Bowling Green | Enrolling | 2+ (child through adult) | $975 | Request Info | |
| Obesity A Study Evaluating the Efficacy of an Investigational Medication in Adults with Obesity | Evansville | Coming Soon | 40+ | $1530 | Request Info | |
| INFANT FORMULA & BREASTFEEDING Infant Formula for Healthy Babies | Evansville Owensboro | Enrolling | Newborns | $625 + formula | Request Info | |
| LUPUS (SLE) A Randomized, Placebo-Controlled Clinical Trial for the Treatment of Systemic Lupus Erythematosus | Evansville | Enrolling | 18 - 65 | $800 | Request Info | |
| LUPUS NEPHRITIS A Safety, efficacy and tolerability study for patients with active Lupus Nephritis | Evansville | Enrolling | 18 - 75 | $4625 ($125 per visit) | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Enrolling | 6 - 17 | $200/$350 | Request Info | |
| MENINGOCOCCAL VACCINE Safety and Immunogenicity of a Meningococcal B vaccine when Administered Together with the MENVEO (MenACWY) Vaccine in healthy subjects age 16 - 18 | Evansville | Enrolling | 16-18 | $300 | Request Info | |
| PSORIASIS A Double-blind, Placebo-controlled Study to Investigate the Efficacy of an Investigational Oral Medication of Moderate to Severe Plaque Psoriasis | Owensboro Evansville | Enrolling | 18-75 | Up to $585 | Request Info | |